These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3251247)

  • 1. Prevention of soman toxicity after the continuous administration of physostigmine.
    Lim DK; Ito Y; Yu ZJ; Hoskins B; Ho IK
    Pharmacol Biochem Behav; 1988 Nov; 31(3):633-9. PubMed ID: 3251247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning.
    Wetherell JR
    J Pharm Pharmacol; 1994 Dec; 46(12):1023-8. PubMed ID: 7714714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs.
    Philippens IH; Melchers BP; Olivier B; Bruijnzeel PL
    Pharmacol Biochem Behav; 2000 Jan; 65(1):175-82. PubMed ID: 10638651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic transdermal treatment with physostigmine and scopolamine against soman intoxication in guinea-pigs.
    Meshulam Y; Davidovici R; Wengier A; Levy A
    J Appl Toxicol; 1995; 15(4):263-6. PubMed ID: 7594194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trihexyphenidyl enhances physostigmine prophylaxis against soman poisoning in guinea pigs.
    Lim DK; Hoskins B; Ho IK
    Fundam Appl Toxicol; 1991 Apr; 16(3):482-9. PubMed ID: 1855620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subchronic administration of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity.
    Lallement G; Foquin A; Dorandeu F; Baubichon D; Carpentier P
    Drug Chem Toxicol; 2001 May; 24(2):165-80. PubMed ID: 11360433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection by sustained release of physostigmine and procyclidine of soman poisoning in rats.
    Choi EK; Park D; Yon JM; Hur GH; Ha YC; Che JH; Kim J; Shin S; Jang JY; Hwang SY; Seong YH; Kim DJ; Kim JC; Kim YB
    Eur J Pharmacol; 2004 Nov; 505(1-3):83-91. PubMed ID: 15556140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity study of continuous administration of physostigmine salicylate.
    Lim DK; Ito Y; Stewart T; Hoskins B; Ho IK
    Pharmacol Biochem Behav; 1988 Nov; 31(3):627-31. PubMed ID: 3251246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of subacute administration of physostigmine on blood acetylcholinesterase activity, motor performance, and soman intoxication.
    Harris LW; Anderson DR; Lennox WJ; Solana RP
    Toxicol Appl Pharmacol; 1989 Feb; 97(2):267-71. PubMed ID: 2922758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subchronic physostigmine pretreatment in guinea pigs: effective against soman and without side effects.
    Philippens IH; Busker RW; Wolthuis OL; Olivier B; Bruijnzeel PL; Melchers BP
    Pharmacol Biochem Behav; 1998 Apr; 59(4):1061-7. PubMed ID: 9586868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress adversely affects efficacy of physostigmine-scopolamine pretreatment against soman in guinea pigs.
    Philippens IH; Joosen MJ; Vanwersch RA
    Pharmacol Biochem Behav; 2005 Sep; 82(1):125-32. PubMed ID: 16126267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis against organophosphate poisoning by sustained release of scopolamine and physostigmine.
    Meshulam Y; Cohen G; Chapman S; Alkalai D; Levy A
    J Appl Toxicol; 2001 Dec; 21 Suppl 1():S75-8. PubMed ID: 11920924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of subacute pretreatment with carbamate together with acute adjunct pretreatment against nerve agent exposure.
    Anderson DR; Harris LW; Lennox WJ; Solana RP
    Drug Chem Toxicol; 1991; 14(1-2):1-19. PubMed ID: 1889370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the response surfaces of two cholinolytics when used in combination with physostigmine as a pretreatment against organophosphate challenge.
    Solana RP; Gennings C; Anderson D; Carter WH; Carchman RA; Harris LW
    Drug Chem Toxicol; 1989; 12(3-4):197-219. PubMed ID: 2632243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylcholinesterase inhibition by (+)physostigmine and efficacy against lethality induced by soman.
    Harris LW; Anderson DR; Pastelak AM; Vanderpool B
    Drug Chem Toxicol; 1990; 13(2-3):241-8. PubMed ID: 2276342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality.
    Lennox WJ; Harris LW; Talbot BG; Anderson DR
    Life Sci; 1985 Sep; 37(9):793-8. PubMed ID: 4033355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment efficacy in a soman-poisoned guinea pig model: added value of physostigmine?
    Joosen MJ; Smit AB; van Helden HP
    Arch Toxicol; 2011 Mar; 85(3):227-37. PubMed ID: 20842348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of anti-convulsant and life-preserving capacities of three types of auto-injector therapies against soman intoxication in rats.
    Myhrer T; Enger S; Aas P
    Drug Test Anal; 2013 Aug; 5(8):693-701. PubMed ID: 22977014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful pretreatment/therapy of soman, sarin and VX intoxication.
    Lennox WJ; Harris LW; Anderson DR; Solana RP; Murrow ML; Wade JV
    Drug Chem Toxicol; 1992; 15(4):271-83. PubMed ID: 1459040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two medical therapies very effective shortly after high levels of soman poisoning in rats, but only one with universal utility.
    Myhrer T; Enger S; Mariussen E; Aas P
    Toxicology; 2013 Dec; 314(2-3):221-8. PubMed ID: 23959147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.